Experience

Cooley Secures Win for Liquidia to Launch First Product

April 5, 2024

Cooley successfully lifted a Hatch-Waxman injunction for Liquidia Technologies, a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products, enabling Liquidia to launch its new drug, Yutrepia.

Read more

Related contacts

Sanya Sukduang
Partner, Washington, DC
Jonathan Davies
Partner, Washington, DC
Daniel Knauss
Partner, Palo Alto
Adam Pivovar
Partner, Washington, DC
Robert Minn
Associate, Palo Alto
Lauren Strosnick
Associate, Palo Alto
Jennifer Volk-Fortier
Associate, Washington, DC
Sam Whitt
Associate, Washington, DC
Larissa Diaz
Senior Paralegal, Washington, DC
Jeannine Douglas
Paralegal Specialist, Palo Alto
Melissa Eskola
Paralegal Specialist, Reston
Loreylys Feliciano
Paralegal Specialist, Chicago
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Admissions and credentials

District of Columbia

Virginia

Registered to practice before the United States Patent and Trademark Office (USPTO)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.